Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 15, 2015

View Archived Issues

Sun Pharma announces collaboration to develop recombinant enzyme for stroke and glioblastoma

AstraZeneca and Wallenberg Centre for Protein Research collaborate to study secretome

Andes Biotechnologies begins first-in-human study evaluating Andes-1537

Anti-GDF8 MAb demonstrates efficacy in the treatment of sarcopenia

ImmBio begins first-in-human studies of PnuBioVax

Biogen begins phase I/II study of ISIS-SOD1-Rx in patients with ALS

Adocia and Lilly report phase I results for BioChaperone Lispro U200

Enrollment open in phase II/III study of TC BioPharm's ImmuniCell

Kyras Therapeutics launched to develop Ras family inhibitors for cancer

NeuroQuest extends validation trials of Alzheimer's disease blood test

Compound based on steroid hormone 20-hydroxyecdysone may improve sarcopenic obesity

FDA grants orphan drug designation to cromolyn sodium (inhaled) for mastocytosis

Atara Biotherapeutics reports data from proof-of-concept trial of PINTA-745

MAT-2501 granted QIDP designation by the FDA

Flindokalner given FDA orphan drug designation for Fragile X Syndrome

Horizon Pharma to acquire Crealta

Tuning T cell affinity improves bispecific antibody efficacy

New SARM has good safety and efficacy profile in monkeys

GlaxoSmithKline discloses ROR-gamma modulators

Cardioxyl Pharmaceuticals and Johns Hopkins University patent nitroxyl donors

Idenix Pharmaceuticals announces anticancer nucleoside derivatives

Sage Therapeutics presents GABA-A receptor modulators

CiRA and Takeda partner to develop clinical applications of induced pluripotent stem cells

Rebiotix starts clinical trial of RBX-2600 in children with ulcerative colitis

Akebia Therapeutics and Mitsubishi Tanabe Pharma sign agreement for vadadustat in Asia

Potassium channel modulator AUT-00206 affects negative symptoms in schizophrenia model

DMX-200 drug combination given FDA orphan designation for focal segmental glomerulosclerosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...